LIK.DE
LIMES Schlosskliniken AG [LIK.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LIK.DE Stock Summary
Top 10 Correlated ETFs
LIK.DE
Top 10 Correlated Stocks
LIK.DE
In the News
LIK.DE Financial details
Company Rating
Buy
Market Cap
103.2M
Income
6.81M
Revenue
66.21M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
177
Optionable
No
Shortable
Yes
Earnings
31 May 2021
P/E
36.12
Forward P/E
-
PEG
5.82
P/S
5.82
P/B
7.49
P/C
-
P/FCF
45.57
Quick Ratio
2.39
Current Ratio
2.78
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
23.24
EPS next Y
-
EPS next Q
-
EPS this Y
-28.66%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
35.52%
Revenue Q/Q
67.46%
EPS Q/Q
74.69%
-
-
-
-
SMA20
15.05%
SMA50
16.22%
SMA100
24.19%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
38%
ROC
0.27%
Gross Margin
43%
Oper. Margin
39%
Profit Margin
16%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
238.0-386.0
52W High
-8.29%
52W Low
+48.74%
RSI
70
Rel Volume
29.24
Avg Volume
33
Volume
965
Perf Week
8.59%
Perf Month
22.07%
Perf Quarter
43.9%
Perf Half Y
29.2%
-
-
-
-
Beta
0.48
-
-
Volatility
7.38%, 22.15%
Prev Close
-1.12%
Price
354
Change
-1.12%
LIK.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 27.91 | 37.57 | 79.93 | 98.25 | 127.53 | |
| Net income per share | -2.81 | -2.37 | 13.45 | 14.34 | 10.23 | |
| Operating cash flow per share | 5.48 | 2.59 | 15.52 | 26.27 | 0 | |
| Free cash flow per share | 5.48 | -3.42 | -6.23 | 21.66 | 0 | |
| Cash per share | 4.21 | 9.15 | 8.47 | 37.26 | 0 | |
| Book value per share | 11.51 | 9.14 | 21.52 | 37.86 | 0 | |
| Tangible book value per share | -22.51 | -20.73 | -44.48 | -19.52 | 0 | |
| Share holders equity per share | 11.51 | 9.14 | 21.52 | 37.86 | 0 | |
| Interest debt per share | 19.18 | 14.03 | 15.55 | 32.16 | 0 | |
| Market cap | 25.36M | 29.32M | 60.4M | 92.65M | 83.87M | |
| Enterprise value | 29.41M | 30.49M | 62.25M | 90.76M | 83.87M | |
| P/E ratio | -30.74 | -42.22 | 15.31 | 22.04 | 27.96 | |
| Price to sales ratio | 3.1 | 2.66 | 2.58 | 3.22 | 2.24 | |
| POCF ratio | 15.79 | 38.63 | 13.28 | 12.03 | 0 | |
| PFCF ratio | 15.79 | -29.25 | -33.07 | 14.59 | 0 | |
| P/B Ratio | 7.52 | 10.94 | 9.57 | 8.35 | 0 | |
| PTB ratio | 7.52 | 10.94 | 9.57 | 8.35 | 0 | |
| EV to sales | 3.59 | 2.77 | 2.66 | 3.15 | 2.24 | |
| Enterprise value over EBITDA | 112.18 | 36.46 | 10.35 | 10.49 | 17.84 | |
| EV to operating cash flow | 18.31 | 40.17 | 13.68 | 11.79 | 0 | |
| EV to free cash flow | 18.31 | -30.41 | -34.09 | 14.29 | 0 | |
| Earnings yield | -0.03 | -0.02 | 0.07 | 0.05 | 0.04 | |
| Free cash flow yield | 0.06 | -0.03 | -0.03 | 0.07 | 0 | |
| Debt to equity | 1.58 | 1.44 | 0.69 | 0.81 | 0 | |
| Debt to assets | 0.56 | 0.33 | 0.24 | 0.34 | 0 | |
| Net debt to EBITDA | 15.45 | 1.39 | 0.31 | -0.22 | 0 | |
| Current ratio | 3.02 | 4.18 | 3.09 | 4.82 | 0 | |
| Interest coverage | -1.9 | -1.62 | 20.2 | 15.32 | 0 | |
| Income quality | -1.95 | -1.09 | 1.15 | 1.83 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.27 | 0.24 | 0.18 | 0.14 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 1.05 | 0.74 | 1.05 | 0.63 | 0 | |
| Capex to operating cash flow | 0 | -2.32 | -1.4 | -0.18 | 0 | |
| Capex to revenue | 0 | -0.16 | -0.27 | -0.05 | 0 | |
| Capex to depreciation | 0 | -1.39 | -4.29 | -0.51 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 26.99 | 22.07 | 80.71 | 110.52 | 0 | |
| ROIC | -0.06 | -0.07 | 0.41 | 0.26 | 0 | |
| Return on tangible assets | 1.82 | -0.23 | -4.34 | 0.43 | 0 | |
| Graham Net | -13.76 | -18.59 | -26.12 | -7.48 | 0 | |
| Working capital | 1.75M | 3.28M | 4.08M | 12.36M | 0 | |
| Tangible asset value | -6.6M | -6.08M | -13.04M | -5.72M | 0 | |
| Net current asset value | -3.54M | -4.79M | -6.1M | 133.94K | 0 | |
| Invested capital | 1.58 | 1.44 | 0.69 | 0.81 | 0 | |
| Average receivables | 1.11M | 1.23M | 1.97M | 2.85M | 1.53M | |
| Average payables | 573.08K | 672.86K | 675.58K | 678.31K | 298.46K | |
| Average inventory | 10.26K | 10.35K | 10.79K | 47.9K | 42.11K | |
| Days sales outstanding | 51.89 | 42.86 | 41.16 | 38.74 | 0 | |
| Days payables outstanding | 45.1 | 26.29 | 18.41 | 12.11 | 0 | |
| Days of inventory on hand | 0.64 | 0.44 | 0.28 | 1.71 | 0 | |
| Receivables turnover | 7.03 | 8.52 | 8.87 | 9.42 | 0 | |
| Payables turnover | 8.09 | 13.89 | 19.83 | 30.14 | 0 | |
| Inventory turnover | 568.98 | 823.15 | 1.3K | 213.64 | 0 | |
| ROE | -0.24 | -0.26 | 0.63 | 0.38 | 0 | |
| Capex per share | 0 | -6.01 | -21.75 | -4.61 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 52.06 | 45.3 | 52.96 | 47.69 | 79.85 | |
| Net income per share | 8.16 | 6.52 | 7.82 | 3.24 | 5.66 | |
| Operating cash flow per share | 10.61 | 18.14 | 8.13 | 10.82 | 0 | |
| Free cash flow per share | 9.82 | 15.42 | 6.24 | -8.73 | 0 | |
| Cash per share | 8.47 | 43.02 | 37.26 | 21.32 | 0 | |
| Book value per share | 21.52 | 29.58 | 37.86 | 42.48 | 0 | |
| Tangible book value per share | -44.48 | -32.33 | -19.52 | -19.31 | 0 | |
| Share holders equity per share | 21.52 | 29.58 | 37.86 | 42.48 | 0 | |
| Interest debt per share | 15.2 | 36.16 | 31.55 | 28.07 | 0 | |
| Market cap | 60.4M | 63.33M | 92.65M | 103.2M | 83.87M | |
| Enterprise value | 62.25M | 60.57M | 90.76M | 105M | 83.87M | |
| P/E ratio | 6.31 | 8.29 | 10.1 | 27.16 | 12.64 | |
| Price to sales ratio | 3.96 | 4.77 | 5.97 | 7.38 | 3.58 | |
| POCF ratio | 19.42 | 11.91 | 38.89 | 32.53 | 0 | |
| PFCF ratio | 20.98 | 14.01 | 50.68 | -40.33 | 0 | |
| P/B Ratio | 9.57 | 7.3 | 8.35 | 8.29 | 0 | |
| PTB ratio | 9.57 | 7.3 | 8.35 | 8.29 | 0 | |
| EV to sales | 4.08 | 4.56 | 5.85 | 7.51 | 3.58 | |
| Enterprise value over EBITDA | 16.66 | 14.66 | 20.07 | 36.44 | -11.79 | |
| EV to operating cash flow | 20.01 | 11.39 | 38.1 | 33.1 | 0 | |
| EV to free cash flow | 21.62 | 13.4 | 49.65 | -41.03 | 0 | |
| Earnings yield | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 | |
| Free cash flow yield | 0.05 | 0.07 | 0.02 | -0.02 | 0 | |
| Debt to equity | 0.69 | 1.2 | 0.81 | 0.65 | 0 | |
| Debt to assets | 0.24 | 0.37 | 0.34 | 0.3 | 0 | |
| Net debt to EBITDA | 0.5 | -0.67 | -0.42 | 0.62 | 0 | |
| Current ratio | 3.09 | 4.1 | 4.82 | 2.78 | 0 | |
| Interest coverage | 23.39 | 16.6 | 14.23 | 9.95 | 0 | |
| Income quality | 1.3 | 2.78 | 1.04 | 3.34 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.18 | 0.14 | 0.14 | 0.16 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 1.05 | 0.64 | 0.63 | 0.69 | 0 | |
| Capex to operating cash flow | -0.07 | -0.15 | -0.23 | -1.81 | 0 | |
| Capex to revenue | -0.02 | -0.06 | -0.04 | -0.41 | 0 | |
| Capex to depreciation | -0.26 | -0.69 | -0.37 | -5.31 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 62.85 | 65.86 | 81.62 | 55.65 | 0 | |
| ROIC | 0.25 | 0.13 | 0.13 | 0.07 | 0 | |
| Return on tangible assets | -2.63 | 0.19 | 0.24 | 0.11 | 0 | |
| Graham Net | -26.12 | -17.91 | -7.48 | -18.77 | 0 | |
| Working capital | 4.08M | 12.36M | 12.36M | 6.94M | 0 | |
| Tangible asset value | -13.04M | -9.48M | -5.72M | -5.66M | 0 | |
| Net current asset value | -6.1M | -3.39M | 133.94K | -3.18M | 0 | |
| Invested capital | 0.69 | 1.2 | 0.81 | 0.65 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 15.58 | 16.61 | 17.72 | 19.11 | 0 | |
| Days payables outstanding | 6.66 | 8.84 | 5.23 | 18.04 | 0 | |
| Days of inventory on hand | 0.1 | 0.74 | 0.74 | 0.78 | 0 | |
| Receivables turnover | 5.78 | 5.42 | 5.08 | 4.71 | 0 | |
| Payables turnover | 13.51 | 10.18 | 17.22 | 4.99 | 0 | |
| Inventory turnover | 885.03 | 121.04 | 122.07 | 115.81 | 0 | |
| ROE | 0.38 | 0.22 | 0.21 | 0.08 | 0 | |
| Capex per share | -0.79 | -2.72 | -1.89 | -19.55 | 0 |
LIK.DE Frequently Asked Questions
What is LIMES Schlosskliniken AG stock symbol ?
LIMES Schlosskliniken AG is a DE stock and trading under the symbol LIK.DE
What is LIMES Schlosskliniken AG stock quote today ?
LIMES Schlosskliniken AG stock price is $354 today.
Is LIMES Schlosskliniken AG stock public?
Yes, LIMES Schlosskliniken AG is a publicly traded company.
Company Profile
- Volume Average 33
- Market Capitalization 103.2M
- Employee 177
- CEO Dr. Gert Michael Frank
- Headquarters Cologne,DE
- IPO Date 2019-03-19
-
Website
https://www.limes-schlosskliniken.de 
LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.
